Source: Shutterstock
Products are selected by our editors, we may earn commission from links on this page.
Artificial intelligence has taken a remarkable step into biology. Researchers at Stanford University and the Arc Institute used a genome-focused AI model called Evo 2 to design entirely new bacteriophages, viruses that infect bacteria, that had never existed in nature. The experiment produced functional viruses capable of infecting and killing E. coli, creating a breakthrough that could eventually help scientists fight antibiotic-resistant infections while also raising difficult questions about how far AI should be allowed to go in designing biological systems.
Evo 2 was used much like a language model, but instead of predicting words, it learned patterns within genetic sequences. Researchers used the system to generate thousands of candidate bacteriophage genomes, then selected hundreds for laboratory testing to determine whether the computer-designed DNA could actually produce functioning viruses.
The numbers show both the scale of the experiment and how difficult it remains to turn an AI design into a working biological system. Researchers synthesized 285 of the selected candidate genomes, and 16 ultimately produced functional bacteriophages capable of infecting E. coli. The successful viruses had genetic sequences that did not simply reproduce an existing virus, demonstrating that AI could generate workable biological designs that had not previously been found in nature.
The research has an important medical purpose. Bacteriophages naturally attack bacteria, and scientists have long studied them as a potential alternative or supplement to antibiotics as antimicrobial resistance makes some infections increasingly difficult to treat. AI-designed phages could eventually give researchers a faster way to develop viruses specifically suited to attacking problematic bacterial strains.
There is an important distinction between what the researchers actually created and the worst-case scenarios surrounding the technology. The AI system was trained on bacteriophage genetic information, while genetic sequences associated with viruses that infect humans, animals or plants were excluded from the training data as a safety measure. The experiments also involved nonpathogenic E. coli strains and were conducted under enhanced containment conditions.
The concern is about what the underlying capability could eventually make possible. If AI systems become increasingly capable of designing biological systems, researchers worry that similar tools could one day be misused to create harmful pathogens or toxins, potentially lowering some of the technical barriers that have historically limited biological engineering. Experts stress, however, that today’s technology still requires substantial laboratory expertise and physical experimentation, meaning an AI-generated design is not automatically a ready-made biological weapon.
The experiment does not mean someone can simply ask an AI chatbot for a dangerous virus and immediately produce one. Researchers still had to synthesize DNA, assemble biological material and test the resulting candidates in a laboratory. The fact that only 16 of hundreds of synthesized designs proved functional also illustrates how much trial and error remains between an AI-generated genetic sequence and a working organism.
If the technology continues to improve, AI could help scientists search biological possibilities far faster than conventional trial-and-error approaches. Instead of relying only on viruses already discovered in nature, researchers could potentially design phages with specific characteristics suited to particular bacterial targets. That could become increasingly valuable as doctors confront bacteria that no longer respond well to existing antibiotics.
The experiment has intensified a broader debate over whether existing biosecurity rules are sufficient for AI-assisted biological research. Experts have warned that governance needs to develop alongside the technology, including safeguards involving DNA synthesis, laboratory research and access to powerful biological design systems. The challenge is finding rules that protect against misuse without preventing legitimate research that could produce important medical advances.
The creation of functional viruses designed by AI marks a major milestone in synthetic biology, but it is not evidence that AI has suddenly made dangerous human viruses on demand. The Stanford and Arc Institute researchers deliberately focused their experiment on bacteriophages and excluded human, animal and plant pathogens from the training data, while working under strict laboratory controls. At the same time, the study demonstrates that AI can move beyond analyzing biology to designing functional genetic systems, making the need for careful oversight increasingly difficult to ignore.
©Image generated with ChatGPT - This image includes a synthetic performer. Thousands of retirees in…
Source: Shutterstock Miley Cyrus is reflecting on the lessons she learned from her late godmother,…
Source: Reddit / u/mcfw31 / Canva Pro Zendaya has made dramatic hair changes part of…
Image generated with GEM For decades, Nike stood as one of the most dominant brands…
Source: Shutterstock This week, Jared Kushner's push to end the war in Ukraine got overshadowed…
Image generated with ChatGPT - This image includes a synthetic performer. Nearly fifty years ago,…